News Daily News Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure Michael O'Riordan December 30, 2025
News Daily News PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI L.A. McKeown November 04, 2025
News Daily News Risk Factors Present in Nearly All Patients Who Develop CVD Michael O'Riordan October 02, 2025
News Daily News Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC Yael L. Maxwell August 18, 2025
News Daily News Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data L.A. McKeown July 24, 2025
News Daily News Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC Michael O'Riordan June 25, 2025
News Daily News Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients Michael O'Riordan June 16, 2025
News Daily News Majority of US Adults Have High Long-term Risk of CVD: NHANES Michael O'Riordan June 13, 2025
News Daily News Finerenone Cuts Intensification of Oral Diuretics in Outpatient Setting: FINEARTS-HF Michael O'Riordan March 03, 2025
News Daily News Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study Michael O'Riordan January 22, 2025
News Daily News Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit Michael O'Riordan January 13, 2025
News Daily News Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review Todd Neale January 09, 2025
News Daily News FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity L.A. McKeown December 13, 2024
News Daily News Rethinking the Evidence for ICDs for HFrEF in Light of Today’s GDMT L.A. McKeown December 05, 2024
News Daily News Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results Michael O'Riordan December 04, 2024
News Daily News CMS Proposal Would Expand Medicare, Medicaid Coverage for GLP-1 Drugs Todd Neale November 27, 2024
News Daily News AHA Statement Outlines Cardiac Contributions to Brain Health L.A. McKeown October 11, 2024
News Daily News Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows L.A. McKeown October 09, 2024